I am a
Home I AM A Search Login

Papers of the Week


2023 Feb


Cephalalgia


43


2

Alopecia as an emerging adverse event to CGRP monoclonal antibodies: Cases Series, evaluation of FAERS, and literature review.

Authors

Ruiz M, Cocores A, Tosti A, Goadsby PJ, Monteith TS
Cephalalgia. 2023 Feb; 43(2):3331024221143538.
PMID: 36739513.

Abstract

Alopecia is associated with erenumab post-marketing, but no cases have been described.